company

Texas Roadhouse

FAIRR Commentary

Texas Roadhouse has made progress over the last year with the release of a public policy on antibiotics and animal welfare that is in line with FDA guidance, and focused only on eliminating the use of medically important antibiotics for growth promotion. Antibiotics are still used for disease prevention in healthy animals. This means the company’s policy lags behind its U.S. peers, many of whom have moved beyond FDA guidance towards eliminating the use of medically important antibiotics from their supply chains. The policy is also not supported by any time-bound commitments to reduce antibiotics use.

FAIRR Recommendations

We are encouraged by Texas Roadhouse’s commitment to antibiotics stewardship. However, we would encourage the company to further strengthen their programme by:

  • Extending their policy to cover all relevant animal-derived proteins where antibiotics are prevalent and clarifying the geographic scope of the policy.
  • Extending the scope of their policy to phase out the routine use of all antibiotics and/ or only use antibiotics when there is a disease present and administered by a veterinarian.
  • Setting targets and timelines for implementation.
  • Committing to third-party audits across all relevant markets and species to ensure supplier compliance. Reporting more comprehensively and publicly on implementation progress including antibiotics use. 
  • Reporting more comprehensively and publicly on implementation progress including antibiotics use. 

Company Comment

No information provided

See the company response to the engagement here.